A detailed history of Balyasny Asset Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 200,000 shares of ACAD stock, worth $2.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200,000
Holding current value
$2.96 Million
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.62 - $18.42 $11.3 Million - $14.2 Million
772,146 New
772,146 $12.5 Million
Q4 2023

Feb 14, 2024

BUY
$20.78 - $31.77 $5.91 Million - $9.04 Million
284,557 Added 1743.82%
300,875 $9.42 Million
Q3 2023

Nov 14, 2023

BUY
$20.84 - $33.47 $340,067 - $546,163
16,318 New
16,318 $340,000
Q4 2022

Feb 14, 2023

BUY
$14.2 - $18.63 $36,607 - $48,028
2,578 New
2,578 $41,000
Q2 2022

Aug 15, 2022

BUY
$13.01 - $27.22 $135,173 - $282,815
10,390 New
10,390 $146,000
Q1 2022

May 16, 2022

SELL
$20.94 - $27.5 $1.79 Million - $2.36 Million
-85,687 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $726,855 - $1.17 Million
-43,291 Reduced 33.56%
85,687 $2 Million
Q3 2021

Nov 15, 2021

BUY
$15.78 - $24.77 $2.04 Million - $3.19 Million
128,978 New
128,978 $2.14 Million
Q4 2020

Feb 16, 2021

SELL
$41.04 - $56.79 $2.79 Million - $3.85 Million
-67,864 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$36.42 - $57.0 $2.19 Million - $3.42 Million
60,072 Added 770.94%
67,864 $2.8 Million
Q2 2020

Aug 14, 2020

BUY
$39.26 - $52.73 $305,913 - $410,872
7,792 New
7,792 $378,000
Q1 2019

May 15, 2019

SELL
$16.17 - $27.38 $1.27 Million - $2.16 Million
-78,845 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$14.32 - $22.92 $16.9 Million - $27 Million
-1,177,231 Reduced 93.72%
78,845 $1.28 Million
Q3 2018

Nov 14, 2018

BUY
$13.03 - $21.81 $15.3 Million - $25.6 Million
1,173,483 Added 1420.8%
1,256,076 $26.1 Million
Q2 2018

Aug 14, 2018

SELL
$15.07 - $22.34 $4.15 Million - $6.15 Million
-275,365 Reduced 76.93%
82,593 $1.26 Million
Q4 2017

Feb 14, 2018

BUY
$26.84 - $39.14 $9.61 Million - $14 Million
357,958
357,958 $10.8 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.